| The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells (NCT03057340) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2017-06-01 |
| Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study (NCT03072199) | Papworth Hospital NHS Foundation Trust | 2017-06-01 |
| Pharmacokinetics and Safety Study of ASKB1202 in Chinese Healthy Subjects (NCT03115762) | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 2017-06-01 |
| PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors (NCT03149549) | CytomX Therapeutics | 2017-06-01 |
| EEG Studies of IV Methylphenidate-Induced Emergence From Anesthesia (NCT02429076) | Massachusetts General Hospital | 2017-06-01 |
| Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy (NCT03118349) | BioNTech Research & Development, Inc. | 2017-06-01 |
| Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors (NCT03171220) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2017-06-01 |
| A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets (NCT03151720) | Xian-Janssen Pharmaceutical Ltd. | 2017-06-01 |
| Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat (NCT02802163) | H. Lee Moffitt Cancer Center and Research Institute | 2017-06-01 |
| High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women (NCT03037593) | University of Minnesota | 2017-06-01 |
| Single Dose Recombinant Human Follicle Stimulating Hormone Fc Husion Protein (KN015) in Healthy Volunteers (NCT03192527) | Alphamab Jilin Co., Ltd. | 2017-06-01 |
| OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol (NCT03881904) | Ain Shams University | 2017-06-01 |
| Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP) (NCT02782325) | University of North Carolina, Chapel Hill | 2017-06-01 |
| Arterial Imaging of Inflammation and Resolution After Endovascular Surgery (NCT03590769) | University of California, San Francisco | 2017-06-01 |
| Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia (NCT02240173) | Federal Neuro-Psychiatric Hospital, Yaba | 2017-06-01 |
| A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions (NCT03512808) | Daewoong Pharmaceutical Co. LTD. | 2017-06-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL201 in Healthy Volunteers (NCT04551534) | Denali Therapeutics Inc. | 2017-06-01 |
| Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas (NCT02030184) | University of Maryland, Baltimore | 2017-06-01 |
| Inovium Ovarian Rejuvenation Trials (NCT03178695) | Ascendance Biomedical | 2017-06-01 |
| Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer (NCT02718144) | Pantarhei Oncology B.V. | 2017-06-01 |
| Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) (NCT02564536) | Washington University School of Medicine | 2017-06-01 |
| A Study Evaluating UCART019 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma (NCT03166878) | Chinese PLA General Hospital | 2017-06-01 |
| Alirocumab and Reverse Cholesterol Transport (NCT03014830) | Washington University School of Medicine | 2017-06-01 |
| Preoperative Levator Ani Muscle Injection and Pudendal Nerve Block for Pain Control After Vaginal Reconstructive Surgery (NCT03040011) | Lauren Giugale, MD | 2017-06-01 |
| Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women (NCT03116022) | University of Sao Paulo | 2017-06-01 |
| Radiation Use During Vemurafenib Treatment (NCT01843738) | University of Utah | 2017-06-01 |
| Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source (NCT02843945) | CivaTech Oncology | 2017-05-31 |
| Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer (NCT03170206) | Dana-Farber Cancer Institute | 2017-05-31 |
| A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes (NCT03115099) | Eli Lilly and Company | 2017-05-31 |
| Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer (NCT03009058) | Immodulon Therapeutics Ltd | 2017-05-31 |
| A Study To Evaluate The Safety, Pharmacokinetics/Pharmacodynamics (PK/PD) and Food Effect Of LC51-0255 (NCT03174613) | LG Chem | 2017-05-31 |
| A Study to Evaluate the Effect of the Potent Cytochrome P-450 3A4 (CYP3A4) Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-954 in Healthy Adult Participants (NCT03173170) | Takeda | 2017-05-31 |
| Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam (NCT03126578) | LEO Pharma | 2017-05-31 |
| Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors (NCT02631733) | National Cancer Institute (NCI) | 2017-05-31 |
| Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme (NCT03170141) | Shenzhen Geno-Immune Medical Institute | 2017-05-31 |
| Relative Bioavailability Among Different Eutropin Formulations (NCT03154840) | LG Chem | 2017-05-31 |
| Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas (NCT03277924) | Grupo Espanol de Investigacion en Sarcomas | 2017-05-31 |
| Pharmacokinetics of Fevipiprant (QAW039) in Patients With Hepatic Impairment Compared to Matched Healthy Subjects (NCT03048448) | Novartis Pharmaceuticals | 2017-05-31 |
| A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis (NCT03056989) | Spyryx Biosciences, Inc. | 2017-05-31 |
| Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers (NCT03151499) | Boehringer Ingelheim | 2017-05-30 |
| A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64140284 in Healthy Participants (NCT03180762) | Janssen Research & Development, LLC | 2017-05-30 |
| The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer (NCT03162562) | CanariaBio Inc. | 2017-05-30 |
| A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic Fibrosis (NCT02950805) | AstraZeneca | 2017-05-30 |
| Oral Remimazolam With and Without Alcohol in Healthy Female Subjects (NCT04113343) | Paion UK Ltd. | 2017-05-30 |
| Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis (NCT03174587) | Corestemchemon, Inc. | 2017-05-30 |
| Phase I Trial of Measles Vectored Chikungungya Vaccine (NCT03028441) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-05-30 |
| A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial (NCT02618902) | University Hospital, Antwerp | 2017-05-30 |
| Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer (NCT02926690) | OncoTherapy Science, Inc. | 2017-05-29 |
| Safety and Protective Efficacy of Pb(PfCS@UIS4) (NCT03138096) | Radboud University Medical Center | 2017-05-29 |
| Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male Subjects (NCT03200496) | Dong-A ST Co., Ltd. | 2017-05-29 |
| A Study of AK-01 (LY3295668) in Solid Tumors (NCT03092934) | Eli Lilly and Company | 2017-05-29 |
| A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration. (NCT03169959) | AstraZeneca | 2017-05-29 |
| A Study of KY1005 in Healthy Volunteers (NCT03161288) | Kymab Limited | 2017-05-29 |
| Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency (NCT02808052) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2017-05-29 |
| A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin's Lymphoma (NCT03343652) | St. Petersburg State Pavlov Medical University | 2017-05-27 |
| Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors (NCT03102320) | Bayer | 2017-05-26 |
| Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors (NCT03114319) | Novartis Pharmaceuticals | 2017-05-26 |
| Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas (NCT03178032) | Clinica Universidad de Navarra, Universidad de Navarra | 2017-05-26 |
| An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies (NCT03144661) | Incyte Corporation | 2017-05-25 |
| Nivolumab With Chemotherapy in Refractory MDS (NCT03259516) | St. Petersburg State Pavlov Medical University | 2017-05-25 |
| Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects (NCT03138356) | AstraZeneca | 2017-05-25 |
| Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder (NCT03065335) | National Institute of Mental Health (NIMH) | 2017-05-25 |
| A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread (NCT03158272) | Bristol-Myers Squibb | 2017-05-25 |
| Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia (NCT02791919) | National Cancer Institute (NCI) | 2017-05-25 |
| Natural Vascular Scaffold (NVS) Therapy (NCT03148808) | Alucent Biomedical | 2017-05-25 |
| Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED) (NCT03116971) | EMD Serono Research & Development Institute, Inc. | 2017-05-25 |
| Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers (NCT02906995) | Friends Research Institute, Inc. | 2017-05-25 |
| A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus (NCT03166124) | Eli Lilly and Company | 2017-05-24 |
| Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I (NCT02702115) | Sangamo Therapeutics | 2017-05-24 |
| Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive Cancers (NCT03294252) | Institut Cancerologie de l'Ouest | 2017-05-24 |
| Dose Escalating Study of BPI-3016 in Healthy Subjects (NCT03188848) | Betta Pharmaceuticals Co., Ltd. | 2017-05-24 |
| Study of ONCOFID-P-B™ (PACLITAXEL-HYALURONIC ACID) (NCT04798703) | Fidia Farmaceutici s.p.a. | 2017-05-24 |
| Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection (NCT03167411) | Theracos | 2017-05-24 |
| PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients (NCT03064854) | Novartis Pharmaceuticals | 2017-05-24 |
| Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia (NCT02838316) | Peter Belafsky, MD | 2017-05-24 |
| A Study of LY3002815 in Healthy Participants (NCT03148431) | Eli Lilly and Company | 2017-05-24 |
| A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects (NCT03135509) | Celgene | 2017-05-24 |
| Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer (NCT02862275) | National Cancer Institute (NCI) | 2017-05-24 |
| A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma (NCT03136653) | Molecular Partners AG | 2017-05-23 |
| Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients (NCT02987829) | Tracon Pharmaceuticals Inc. | 2017-05-23 |
| Open-label V565 Target Engagement Study (NCT03705117) | VHsquared Ltd. | 2017-05-23 |
| Normal Breathing and Swallowing in Healthy Volunteers (NCT03122145) | University of Florida | 2017-05-23 |
| PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer (NCT03166085) | Memorial Sloan Kettering Cancer Center | 2017-05-23 |
| A Study to Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects (NCT03187015) | Syndax Pharmaceuticals | 2017-05-23 |
| A Study of HMPL-453 in Patients With Advanced Solid Malignancies (NCT03160833) | Hutchison Medipharma Limited | 2017-05-23 |
| A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis (NCT03000673) | Bristol-Myers Squibb | 2017-05-23 |
| Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T) (NCT03173417) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2017-05-23 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult Subjects (NCT03108755) | Astellas Pharma Europe B.V. | 2017-05-23 |
| Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma (NCT03061188) | Northwestern University | 2017-05-23 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects (NCT03155503) | Suven Life Sciences Limited | 2017-05-22 |
| Bioavailability of Infacort When Administered Onto Food Compared to Direct Oral Administration (NCT03178214) | Neurocrine UK Limited | 2017-05-22 |
| Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors (NCT02589522) | National Cancer Institute (NCI) | 2017-05-22 |
| Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers (NCT03459391) | PHARMENTERPRISES LLC | 2017-05-22 |
| Bioavailability, Safety, and Tolerability of BIS-001 ER (NCT03156439) | Supernus Pharmaceuticals, Inc. | 2017-05-22 |
| EVALUATION OF AN INNOVATIVE TREATMENT FOR RADIOCARPAL OSTEOARTHRITIS USING INTRA-ARTICULAR INJECTION OF A MIXTURE OF AUTOLOGOUS MICROFAT AND AUTOLOGOUS PLATELET-RICH PLASMA (NCT03164122) | Assistance Publique Hopitaux De Marseille | 2017-05-22 |
| Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan (NCT03143166) | Boehringer Ingelheim | 2017-05-22 |
| HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors (NCT03284502) | Hanmi Pharmaceutical Company Limited | 2017-05-22 |
| Safinamide Steady State Interaction With Rosuvastatin (NCT03216304) | Cross Research S.A. | 2017-05-22 |
| Effect of Armodafinil on Simulated Driving (NCT02468856) | University of Florida | 2017-05-21 |
| The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects (NCT03092102) | Sunshine Lake Pharma Co., Ltd. | 2017-05-20 |